K.N. received manuscript fees from Sumitomo Pharma and Wiley Japan within the past 3 years. Y.O. received manuscript fees from Sumitomo Pharma within the past 3 years. T.Y. (T. Yatomi) received grants from Japan Society for the Promotion of Science (21K07508, 23KJ1898), and The Keio University Doctorate Student Grant-in-Aid Program from Ushioda Memorial Fund (Graduate school recommendation) within the past 3 years. K.Y. (K. Yonezawa) received manuscript fees from Sumitomo Pharma and Wiley Japan within the past 3 years. S. Tomiyama. received a fellowship from Nakatani Foundation and grants from Japan Society for the Promotion of Science (22KJ2687). N.N. received manuscript or speaker fees from Sumitomo Pharma and Wiley Japan within the past 3 years. K.K. received speaker fees from Janssen and Eisai Pharmaceutical within the past 3 years. S.H. received the JSPS Research Fellowship for Young Scientists (DC1), and The Keio University Doctorate Student Grant-in-Aid Program from Ushioda Memorial Fund. S.N. received grants from Japan Society for the Promotion of Science (18H02755, 22H03002), Japan Agency for Medical Research and development (AMED), Japan Research Foundation for Clinical Pharmacology, Naito Foundation, Takeda Science Foundation, and Uehara Memorial Foundation within the past 3 years. S.N. also received research support, manuscript fees or speaker’s honoraria from Dainippon Sumitomo Pharma, Meiji Seika Pharma, Otsuka Pharmaceutical, Shionogi, and Yoshitomi Yakuhin within the past 3 years. T. Yamada received speaker fees from Maruishi Pharmaceutical within the past 3 years. S.I. received a grant from Japan Society for the Promotion of Science (23K14824) within the past 3 years. Y.F. received a grant from Japan Science and Technology Agency (JPMJFS2140) within the past 3 years. H.U. received grants from Daiichi Sankyo, Eisai, Mochida, Otsuka, and Sumitomo Pharma; speaker’s fees from Eisai, Lundbeck, Meiji Seika Pharma, Otsuka, Boehringer Ingelheim Japan, MSD, and Sumitomo Pharma; and advisory board fees from Lundbeck, Sumitomo Pharma, Takeda Pharmaceutical Company, and Boehringer Ingelheim Japan for the past 3 years. H.T. received manuscript or speaker fees from Sumitomo Pharma, Janssen Pharmaceutical, Otsuka Pharmaceutical, Takeda, Wiley Japan, and Yoshitomi Yakuhin within the past 3 years. Other authors have nothing to disclose.
PubMed
